Ozdemır Sule, Oruc Muhammet Ali, Yazıcıoglu Bahadır, Turkan Sibel
Faculty of Medicine, Department of Public Health, Samsun University, Samsun, Turkey.
Faculty of Medicine, Department of Family Medicine, Samsun University, Samsun, Turkey.
Postgrad Med. 2023 Nov;135(8):818-823. doi: 10.1080/00325481.2023.2285726. Epub 2024 Jan 10.
Hemoglobinopathies are a global public health problem with high mortality and morbidity and very expensive treatment. Disease can be reduced and prevented with hemoglobinopathy screening tests. It is possible to identify carriers with the hemoglobinopathy screening program applied in many countries of the world and in Turkey. This study aims to evaluate the results of the national premarital hemoglobinopathy screening program carried out in primary healthcare institutions.
The research is of epidemiological and cross-sectional type. Electrophoresis results examined within the scope of the premarital hemoglobinopathy screening program in Samsun between 1 January 2019 and 31 December 2021 were evaluated retrospectively. Age, gender, year of screening, and hemoglobinopathy screening results were obtained from the records. In the statistical analysis of the data, < 0.05 was accepted.
The median age of 52,338 people screened under the hemoglobinopathy screening program was 29.0 (16.0-86.0) years. About 54.1% ( = 28,309) of those who were screened were female, and it was found that the least screening was done in 2020 ( = 15,765 (30.1%)). As a result of the screening, the frequency of the β-thalassemia (β-thal) trait was 1.37% ( = 676), the frequency of the abnormal HbS was 0.04% ( = 20). The frequency of β-thal trait was statistically significantly higher in 2020 (1.5%) compared to other years ( = 0.029). When the results were analyzed by gender, the rate of women with abnormal HbS (3.7%) was significantly higher than the others ( = 0.017).
This study presents the results of the national hemoglobinopathy screening program in Northern Turkey and the β-thal and the abnormal HbS rates were found to be low. The data obtained will be useful in monitoring hemoglobinopathy disorders and evaluating the current program's effectiveness in the future. It will allow decision-makers to implement policy changes and prioritize new programs.
血红蛋白病是一个全球性的公共卫生问题,死亡率和发病率高,治疗费用昂贵。通过血红蛋白病筛查测试可以减少和预防该疾病。在世界上许多国家以及土耳其实施的血红蛋白病筛查项目能够识别携带者。本研究旨在评估在初级医疗机构开展的国家婚前血红蛋白病筛查项目的结果。
本研究为流行病学横断面研究类型。对2019年1月1日至2021年12月31日期间在萨姆松婚前血红蛋白病筛查项目范围内检查的电泳结果进行回顾性评估。从记录中获取年龄、性别、筛查年份和血红蛋白病筛查结果。在数据的统计分析中,P < 0.05被视为有统计学意义。
在血红蛋白病筛查项目下接受筛查的52338人的中位年龄为29.0(16.0 - 86.0)岁。接受筛查者中约54.1%(n = 28309)为女性,发现2020年筛查人数最少(n = 15765(30.1%))。筛查结果显示,β地中海贫血(β - thal)特征的频率为1.37%(n = 676),异常血红蛋白S(HbS)的频率为0.04%(n = 20)。2020年β - thal特征的频率(1.5%)与其他年份相比在统计学上显著更高(P = 0.029)。按性别分析结果时,异常HbS的女性比例(3.7%)显著高于其他人群(P = 0.017)。
本研究呈现了土耳其北部国家血红蛋白病筛查项目的结果,发现β - thal和异常HbS的发生率较低。所获得的数据将有助于监测血红蛋白病疾病,并在未来评估当前项目的有效性。这将使决策者能够实施政策变革并为新的项目确定优先次序。